Drug
Mometasone nasal spray
Mometasone nasal spray is a pharmaceutical drug with 4 clinical trials. Historical success rate of 75.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_3
2
50%
Ph not_applicable
1
25%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 4
Trials by Phase
Phase 32 (50.0%)
Phase 41 (25.0%)
N/A1 (25.0%)
Trials by Status
completed375%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_4
Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis
NCT03705793
completednot_applicable
A Comparison Of Local Anesthetic Agents And Steroid On Tracheal Tube Cuff
NCT04085744
terminatedphase_3
Mometasone vs Budesonide in CRS With Polyposis
NCT03323866
completedphase_3
Clinical Equivalence Study of Mometasone Nasal Spray
NCT01850823
Clinical Trials (4)
Showing 4 of 4 trials
NCT03705793Phase 4
Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis
NCT04085744Not Applicable
A Comparison Of Local Anesthetic Agents And Steroid On Tracheal Tube Cuff
NCT03323866Phase 3
Mometasone vs Budesonide in CRS With Polyposis
NCT01850823Phase 3
Clinical Equivalence Study of Mometasone Nasal Spray
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4